Table 22.
One-, two-, five-, and ten-year relative survival ratesa,b with 95% confidence intervals for selected malignant brain and other central nervous system tumors by selected age-groups, U.S. Cancer Statistics – NPCR Registries, 2001–2015
| Histology | Age- group (years) | Nc | 1-Year | 2-Year | 5-Year | 10-Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |||
| Pilocytic astrocytomad | 0–19 | 9,749 | 98.8 | 98.6–99.0 | 98.3 | 98.0–98.6 | 96.9 | 96.5–97.3 | 95.7 | 95.2–96.2 |
| 20–44 | 2,684 | 97.1 | 96.4–97.7 | 95.5 | 94.5–96.2 | 92.3 | 91.1–93.3 | 89.5 | 88.0–90.9 | |
| 45–54 | 498 | 94.6 | 92.1–96.3 | 88.8 | 85.4–91.4 | 80.4 | 76.0–84.1 | 77.5 | 72.1–82.1 | |
| 55–64 | 301 | 91.1 | 87.0–94.0 | 85.0 | 80.0–88.9 | 74.0 | 67.5–79.4 | 73.6 | 65.2–80.3 | |
| 65–74 | 164 | 82.1 | 74.8–87.4 | 76.5 | 68.3–82.9 | 68.3 | 58.2–76.5 | 63.4 | 51.9–72.9 | |
| 75+ | 88 | 83.0 | 71.3–90.2 | 76.2 | 62.8–85.4 | 67.0 | 50.8–78.9 | 67.0 | 50.8–78.9 | |
| Diffuse astrocytoma | 0–19 | 3,128 | 93.0 | 92.0–93.9 | 87.3 | 86.0–88.5 | 82.8 | 81.3–84.1 | 79.9 | 78.3–81.4 |
| 20–44 | 7,551 | 94.0 | 93.4–94.5 | 87.9 | 87.1–88.6 | 73.1 | 72.0–74.2 | 55.0 | 53.5–56.5 | |
| 45–54 | 3,366 | 78.8 | 77.4–80.2 | 64.4 | 62.7–66.0 | 46.3 | 44.4–48.1 | 35.1 | 33.0–37.2 | |
| 55–64 | 3,104 | 61.0 | 59.2–62.7 | 42.1 | 40.3–43.9 | 26.1 | 24.4–27.9 | 18.4 | 16.6–20.4 | |
| 65–74 | 2,442 | 43.6 | 41.5–45.6 | 26.5 | 24.7–28.4 | 15.5 | 13.9–17.3 | 10.3 | 8.5–12.2 | |
| 75+ | 1,952 | 22.0 | 20.1–24.0 | 12.7 | 11.1–14.3 | 7.7 | 6.3–9.4 | 5.3 | 3.5–7.7 | |
| Anaplastic astrocytoma | 0–19 | 951 | 70.1 | 67.0–72.9 | 41.8 | 38.5–45.1 | 27.8 | 24.7–30.9 | 22.9 | 19.8–26.2 |
| 20–44 | 4,890 | 89.6 | 88.7–90.4 | 77.0 | 75.7–78.2 | 57.9 | 56.3–59.5 | 43.0 | 41.1–44.8 | |
| 45–54 | 2,683 | 73.1 | 71.3–74.8 | 50.0 | 48.0–52.0 | 29.1 | 27.1–31.0 | 22.1 | 20.1–24.1 | |
| 55–64 | 2,881 | 55.9 | 54.0–57.8 | 32.4 | 30.6–34.2 | 15.3 | 13.8–16.9 | 9.8 | 8.3–11.5 | |
| 65–74 | 2,290 | 37.5 | 35.4–39.5 | 17.7 | 16.0–19.4 | 7.7 | 6.4–9.1 | 4.8 | 3.5–6.4 | |
| 75+ | 1,529 | 18.9 | 16.9–21.0 | 7.6 | 6.2–9.1 | 2.9 | 1.9–4.3 | 1.9 | 1.0–3.3 | |
| Unique astrocytoma variants | 0–19 | 596 | 95.7 | 93.7–97.1 | 90.4 | 87.6–92.6 | 80.6 | 76.8–83.8 | 76.5 | 72.1–80.3 |
| 20–44 | 529 | 92.3 | 89.6–94.3 | 86.6 | 83.2–89.3 | 74.5 | 69.9–78.4 | 70.7 | 65.7–75.2 | |
| 45–54 | 163 | 77.2 | 69.8–83.0 | 55.5 | 47.2–63.0 | 39.4 | 31.2–47.5 | 31.4 | 22.6–40.6 | |
| 55–64 | 155 | 62.7 | 54.4–70.0 | 44.3 | 36.0–52.4 | 29.1 | 21.3–37.4 | 21.4 | 13.3–30.6 | |
| 65–74 | 126 | 36.5 | 27.9–45.1 | 27.1 | 19.1–35.7 | -- | -- | -- | -- | |
| 75+ | 124 | 34.4 | 25.6–43.4 | 26.3 | 17.8–35.5 | -- | -- | -- | -- | |
| Glioblastoma | 0–19 | 1,659 | 62.5 | 60.0–64.8 | 36.1 | 33.7–38.6 | 20.8 | 18.7–23.0 | 16.6 | 14.5–18.8 |
| 20–44 | 10,448 | 71.8 | 70.9–72.7 | 43.6 | 42.6–44.6 | 21.9 | 21.0–22.8 | 15.2 | 14.3–16.1 | |
| 45–54 | 20,730 | 58.6 | 57.9–59.2 | 27.1 | 26.4–27.7 | 9.3 | 8.9–9.8 | 5.7 | 5.3–6.2 | |
| 55–64 | 34,309 | 47.4 | 46.9–48.0 | 19.9 | 19.4–20.3 | 5.9 | 5.6–6.2 | 3.5 | 3.2–3.8 | |
| 65–74 | 31,664 | 31.2 | 30.7–31.7 | 12.1 | 11.7–12.5 | 3.9 | 3.6–4.1 | 3.0 | 2.7–3.3 | |
| 75+ | 25,107 | 13.4 | 12.9–13.8 | 4.8 | 4.5–5.2 | 1.9 | 1.7–2.2 | 1.9 | 1.7–2.2 | |
| Oligodendroglioma | 0–19 | 646 | 98.0 | 96.5–98.8 | 96.7 | 94.9–97.8 | 94.8 | 92.6–96.3 | 89.7 | 86.4–92.3 |
| 20–44 | 5,552 | 98.3 | 97.9–98.7 | 96.5 | 96.0–97.0 | 90.1 | 89.1–90.9 | 75.1 | 73.5–76.6 | |
| 45–54 | 2,324 | 95.3 | 94.3–96.1 | 91.3 | 90.0–92.5 | 82.0 | 80.2–83.8 | 68.0 | 65.3–70.6 | |
| 55–64 | 1,370 | 89.9 | 88.1–91.5 | 80.4 | 78.0–82.5 | 69.4 | 66.5–72.2 | 54.4 | 50.4–58.2 | |
| 65–74 | 579 | 78.5 | 74.7–81.8 | 68.5 | 64.2–72.5 | 52.3 | 47.2–57.2 | 35.7 | 29.2–42.3 | |
| 75+ | 277 | 56.0 | 49.5–62.1 | 43.7 | 37.0–50.1 | 31.9 | 24.7–39.2 | 14.7 | 8.5–22.6 | |
| Anaplastic oligodendroglioma | 0–19 | 115 | 85.1 | 77.1–90.5 | 65.8 | 56.1–73.8 | 49.5 | 39.5–58.7 | 39.7 | 29.8–49.4 |
| 20–44 | 1,855 | 95.4 | 94.3–96.3 | 88.9 | 87.3–90.3 | 75.8 | 73.5–77.8 | 61.6 | 58.7–64.4 | |
| 45–54 | 1,140 | 91.2 | 89.3–92.8 | 80.4 | 77.9–82.8 | 66.6 | 63.4–69.7 | 50.0 | 45.9–53.9 | |
| 55–64 | 937 | 79.9 | 77.0–82.4 | 62.0 | 58.6–65.2 | 45.0 | 41.3–48.6 | 34.7 | 30.3–39.0 | |
| 65–74 | 456 | 63.9 | 59.1–68.3 | 47.1 | 42.0–52.0 | 30.3 | 25.2–35.5 | 21.1 | 15.5–27.3 | |
| 75+ | 215 | 43.4 | 36.3–50.3 | 26.8 | 20.5–33.5 | 17.4 | 11.4–24.5 | 13.1 | 6.0–23.0 | |
| Oligoastrocytic tumors | 0–19 | 355 | 92.0 | 88.7–94.5 | 84.3 | 80.0–87.8 | 78.4 | 73.4–82.5 | 71.2 | 65.4–76.2 |
| 20–44 | 3,935 | 96.9 | 96.3–97.4 | 92.4 | 91.5–93.3 | 78.7 | 77.2–80.0 | 59.3 | 57.1–61.3 | |
| 45–54 | 1,361 | 90.2 | 88.5–91.7 | 80.4 | 78.1–82.5 | 64.7 | 61.8–67.4 | 48.5 | 44.8–52.2 | |
| 55–64 | 965 | 78.3 | 75.5–80.9 | 57.3 | 54.0–60.5 | 39.7 | 36.2–43.1 | 31.8 | 27.9–35.8 | |
| 65–74 | 475 | 61.4 | 56.7–65.8 | 42.1 | 37.4–46.8 | 26.0 | 21.5–30.8 | 15.6 | 10.6–21.5 | |
| 75+ | 208 | 30.5 | 24.1–37.1 | 18.2 | 12.9–24.3 | 10.1 | 5.7–16.1 | -- | -- | |
| Ependymal tumors | 0–19 | 2,734 | 95.2 | 94.3–96.0 | 89.8 | 88.5–90.9 | 78.9 | 77.1–80.5 | 69.9 | 67.7–72.0 |
| 20–44 | 3,231 | 97.1 | 96.4–97.6 | 95.2 | 94.3–95.9 | 91.9 | 90.7–92.9 | 88.7 | 87.2–90.1 | |
| 45–54 | 1,835 | 95.8 | 94.7–96.7 | 93.5 | 92.2–94.7 | 89.5 | 87.7–91.0 | 86.1 | 83.6–88.3 | |
| 55–64 | 1,353 | 92.5 | 90.8–93.8 | 90.4 | 88.5–92.0 | 87.3 | 84.8–89.3 | 84.5 | 80.9–87.5 | |
| 65–74 | 785 | 88.6 | 85.9–90.9 | 82.7 | 79.3–85.5 | 77.9 | 73.6–81.6 | 69.0 | 61.9–75.0 | |
| 75+ | 337 | 77.8 | 72.3–82.4 | 76.7 | 70.4–81.8 | 72.8 | 63.7–80.0 | 61.5 | 47.2–73.0 | |
| Glioma malignant, NOS | 0–19 | 6,852 | 82.5 | 81.5–83.4 | 72.4 | 71.3–73.5 | 69.3 | 68.2–70.5 | 68.0 | 66.8–69.2 |
| 20–44 | 3,344 | 90.0 | 88.9–91.0 | 83.4 | 82.0–84.6 | 73.2 | 71.5–74.8 | 64.0 | 61.8–66.1 | |
| 45–54 | 1,621 | 77.1 | 74.9–79.1 | 66.2 | 63.8–68.6 | 55.9 | 53.2–58.6 | 48.0 | 44.8–51.1 | |
| 55–64 | 1,522 | 62.3 | 59.7–64.7 | 50.5 | 47.9–53.1 | 37.6 | 34.8–40.4 | 29.1 | 25.9–32.4 | |
| 65–74 | 1,464 | 41.9 | 39.3–44.5 | 31.4 | 28.9–33.9 | 23.1 | 20.6–25.7 | 18.7 | 15.6–22.0 | |
| 75+ | 2,560 | 19.1 | 17.5–20.7 | 14.6 | 13.1–16.1 | 10.2 | 8.6–11.8 | 7.9 | 5.9–10.1 | |
| Neuronal and mixed neuronal-glial tumors | 0–19 | 282 | 91.7 | 87.7–94.4 | 84.3 | 79.3–88.2 | 78.3 | 72.7–82.9 | 76.8 | 70.9–81.6 |
| 20–44 | 598 | 95.1 | 93.0–96.6 | 90.2 | 87.4–92.4 | 82.6 | 78.8–85.7 | 74.3 | 69.4–78.6 | |
| 45–54 | 419 | 94.8 | 92.0–96.6 | 89.5 | 85.8–92.2 | 83.3 | 78.6–87.0 | 79.4 | 73.1–84.3 | |
| 55–64 | 391 | 90.0 | 86.3–92.7 | 81.6 | 77.0–85.4 | 72.3 | 66.5–77.2 | 64.4 | 56.6–71.2 | |
| 65–74 | 245 | 89.3 | 84.0–92.9 | 86.2 | 80.1–90.6 | 79.4 | 70.9–85.6 | 66.1 | 54.0–75.8 | |
| 75+ | 165 | 75.1 | 66.6–81.7 | 68.1 | 58.5–76.0 | 56.6 | 44.3–67.3 | 34.8 | 18.0–52.2 | |
| Tumors of the pineal region | 0–19 | 422 | 87.2 | 83.5–90.1 | 78.0 | 73.5–81.8 | 64.3 | 59.0–69.1 | 57.2 | 51.3–62.6 |
| 20–44 | 290 | 92.9 | 89.2–95.4 | 85.9 | 81.0–89.6 | 74.9 | 68.6–80.1 | 68.7 | 61.0–75.2 | |
| 45–54 | 116 | 86.6 | 78.6–91.8 | 77.0 | 67.5–84.0 | 70.4 | 59.6–78.8 | 60.1 | 47.3–70.8 | |
| 55–64 | 81 | 85.1 | 74.5–91.5 | 81.4 | 70.0–88.8 | 64.6 | 50.2–75.8 | 47.6 | 28.7–64.3 | |
| 65–74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| 75+ | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| Embryonal tumors | 0–19 | 7,089 | 82.5 | 81.6–83.4 | 73.4 | 72.3–74.4 | 63.6 | 62.4–64.8 | 58.5 | 57.1–59.8 |
| 20–44 | 1,899 | 88.8 | 87.3–90.2 | 80.9 | 79.0–82.7 | 68.3 | 66.0–70.6 | 58.3 | 55.6–61.0 | |
| 45–54 | 308 | 75.6 | 70.3–80.1 | 61.0 | 55.1–66.4 | 51.3 | 45.0–57.2 | 40.1 | 32.8–47.2 | |
| 55–64 | 188 | 62.1 | 54.5–68.8 | 48.5 | 40.8–55.8 | 35.8 | 28.1–43.5 | 23.7 | 16.1–32.3 | |
| 65–74 | 78 | 45.3 | 33.6–56.2 | 23.1 | 13.9–33.7 | -- | -- | -- | -- | |
| 75+ | 64 | 28.9 | 17.9–40.9 | -- | -- | -- | -- | -- | -- | |
| Nerve sheath tumors | 0–19 | 58 | 89.4 | 77.9–95.1 | 81.9 | 68.9–89.9 | 80.0 | 66.6–88.4 | 77.3 | 62.9–86.7 |
| 20–44 | 180 | 84.3 | 78.0–88.9 | 78.4 | 71.5–83.9 | 73.6 | 66.1–79.6 | 70.7 | 62.7–77.3 | |
| 45–54 | 139 | 90.1 | 83.5–94.1 | 85.0 | 77.5–90.2 | 82.1 | 74.1–87.9 | 81.2 | 71.4–88.0 | |
| 55–64 | 105 | 84.1 | 75.2–90.0 | 78.6 | 68.8–85.6 | 75.1 | 64.2–83.1 | 73.1 | 59.5–82.7 | |
| 65–74 | 86 | 94.6 | 84.7–98.2 | 91.2 | 79.5–96.3 | 85.7 | 69.1–93.7 | 83.8 | 63.2–93.5 | |
| 75+ | 57 | 73.1 | 57.5–83.7 | 65.2 | 48.2–77.7 | 58.6 | 39.4–73.6 | 58.6 | 39.4–73.6 | |
| Meningioma | 0–19 | 89 | 91.8 | 83.5–96.0 | 84.0 | 74.0–90.5 | 79.7 | 68.8–87.1 | 78.0 | 66.6–85.9 |
| 20–44 | 600 | 94.0 | 91.7–95.7 | 91.7 | 89.0–93.7 | 84.0 | 80.5–86.9 | 76.8 | 72.5–80.6 | |
| 45–54 | 747 | 91.7 | 89.3–93.5 | 86.1 | 83.2–88.5 | 79.4 | 75.9–82.4 | 74.9 | 70.7–78.5 | |
| 55–64 | 991 | 89.7 | 87.5–91.5 | 84.2 | 81.6–86.5 | 73.8 | 70.4–76.8 | 65.3 | 61.0–69.3 | |
| 65–74 | 1,036 | 84.5 | 82.0–86.8 | 77.7 | 74.7–80.4 | 63.3 | 59.4–66.9 | 57.9 | 53.0–62.4 | |
| 75+ | 1,229 | 69.5 | 66.5–72.3 | 61.3 | 57.9–64.6 | 50.2 | 45.9–54.4 | 39.5 | 32.8–46.0 | |
| Mesenchymal tumors | 0–19 | 169 | 82.4 | 75.6–87.4 | 71.2 | 63.5–77.6 | 61.2 | 52.8–68.6 | 54.1 | 44.9–62.5 |
| 20–44 | 301 | 88.0 | 83.7–91.3 | 84.0 | 79.2–87.9 | 74.5 | 68.6–79.5 | 61.1 | 53.6–67.9 | |
| 45–54 | 179 | 90.7 | 85.1–94.2 | 83.7 | 77.1–88.6 | 75.5 | 67.4–81.8 | 63.6 | 53.6–72.0 | |
| 55–64 | 154 | 85.3 | 78.4–90.2 | 77.2 | 69.1–83.4 | 58.5 | 48.3–67.4 | 47.7 | 35.0–59.4 | |
| 65–74 | 97 | 82.0 | 71.9–88.7 | 76.2 | 64.9–84.2 | 49.7 | 35.8–62.1 | 24.5 | 8.6–44.6 | |
| 75+ | 63 | 58.8 | 44.6–70.6 | 49.5 | 34.8–62.6 | 30.4 | 16.5–45.4 | -- | -- | |
| Other neoplasms related to the meninges |
0–19 | 62 | 95.0 | 85.3–98.4 | 89.7 | 78.5–95.3 | 85.5 | 72.8–92.6 | 77.9 | 62.9–87.4 |
| 20–44 | 224 | 96.0 | 92.3–98.0 | 91.7 | 86.9–94.8 | 86.5 | 80.5–90.8 | 76.7 | 68.0–83.2 | |
| 45–54 | 125 | 95.3 | 89.2–98.0 | 93.9 | 87.0–97.2 | 87.7 | 78.5–93.1 | 76.8 | 63.9–85.5 | |
| 55–64 | 116 | 90.3 | 82.8–94.7 | 84.6 | 75.8–90.4 | 67.0 | 55.9–76.0 | 41.5 | 27.8–54.7 | |
| 65–74 | 103 | 95.0 | 86.2–98.2 | 90.4 | 80.1–95.5 | 84.4 | 70.5–92.1 | 58.5 | 40.0–73.2 | |
| 75+ | 74 | 85.0 | 71.5–92.4 | 79.1 | 63.2–88.7 | 61.3 | 41.3–76.3 | 48.4 | 28.8–65.5 | |
| Lymphoma | 0–19 | 164 | 86.1 | 79.7–90.7 | 80.6 | 73.4–86.1 | 76.0 | 68.2–82.2 | 72.1 | 63.6–79.0 |
| 20–44 | 2,413 | 57.1 | 55.1–59.1 | 52.6 | 50.5–54.6 | 45.9 | 43.8–48.0 | 41.0 | 38.7–43.2 | |
| 45–54 | 2,488 | 64.6 | 62.6–66.5 | 56.8 | 54.7–58.8 | 46.3 | 44.1–48.4 | 35.8 | 33.4–38.2 | |
| 55–64 | 3,688 | 63.4 | 61.8–65.0 | 54.7 | 53.0–56.4 | 42.1 | 40.3–44.0 | 30.6 | 28.4–32.8 | |
| 65–74 | 4,348 | 52.6 | 51.1–54.2 | 43.1 | 41.5–44.7 | 30.1 | 28.5–31.8 | 21.5 | 19.5–23.6 | |
| 75+ | 3,654 | 32.4 | 30.8–34.0 | 23.9 | 22.4–25.5 | 15.8 | 14.3–17.5 | 11.3 | 9.1–13.7 | |
| Other hematopoietic neoplasms | 0–19 | 92 | 92.0 | 83.9–96.1 | 92.0 | 83.9–96.1 | 90.2 | 81.0–95.1 | 90.2 | 81.0–95.1 |
| 20–44 | 89 | 88.7 | 79.8–93.8 | 81.5 | 71.3–88.3 | 74.4 | 62.3–83.2 | 72.4 | 59.6–81.7 | |
| 45–54 | 65 | 86.3 | 74.9–92.8 | 75.3 | 62.4–84.3 | 67.2 | 53.2–77.9 | 60.5 | 44.1–73.5 | |
| 55–64 | 74 | 85.3 | 74.3–91.9 | 72.3 | 59.5–81.6 | 62.1 | 48.1–73.4 | 62.1 | 48.1–73.4 | |
| 65–74 | 63 | 64.5 | 50.9–75.2 | 54.0 | 40.2–65.9 | 40.9 | 26.9–54.5 | 36.5 | 22.4–50.8 | |
| 75+ | -- | -- | -- | -- | -- | -- | -- | -- | -- | |
| Tumors of the pituitary | 0–19 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 20–44 | 134 | 95.6 | 90.2–98.0 | 94.2 | 88.2–97.2 | 89.1 | 81.5–93.7 | 88.3 | 80.0–93.3 | |
| 45–54 | 86 | 89.6 | 80.4–94.6 | 88.7 | 79.1–94.0 | 78.6 | 66.2–86.9 | 73.1 | 58.8–83.2 | |
| 55–64 | 82 | 86.9 | 76.7–92.8 | 83.4 | 72.2–90.4 | 79.8 | 66.6–88.2 | 79.8 | 66.6–88.2 | |
| 65–74 | 72 | 88.9 | 77.6–94.7 | 88.9 | 77.6–94.7 | 78.8 | 63.2–88.4 | 68.7 | 41.4–85.2 | |
| 75+ | 52 | 82.3 | 65.6–91.5 | 79.5 | 59.6–90.3 | 68.9 | 42.6–85.0 | 52.9 | 27.4–73.0 | |
| Neoplasm, unspecified | 0–19 | 435 | 66.6 | 61.9–70.9 | 61.8 | 56.9–66.2 | 58.5 | 53.5–63.1 | 55.8 | 50.5–60.8 |
| 20–44 | 955 | 71.9 | 68.9–74.7 | 66.9 | 63.7–69.8 | 59.4 | 56.0–62.6 | 55.1 | 51.4–58.6 | |
| 45–54 | 809 | 59.3 | 55.8–62.7 | 51.8 | 48.2–55.3 | 44.2 | 40.5–47.8 | 39.0 | 35.0–42.9 | |
| 55–64 | 1,188 | 42.2 | 39.3–45.0 | 34.1 | 31.3–36.9 | 27.5 | 24.8–30.3 | 24.4 | 21.4–27.4 | |
| 65–74 | 1,567 | 27.8 | 25.6–30.1 | 22.4 | 20.3–24.6 | 16.4 | 14.4–18.6 | 15.0 | 12.8–17.3 | |
| 75+ | 5,084 | 14.6 | 13.6–15.7 | 10.8 | 9.9–11.8 | 7.3 | 6.3–8.3 | 5.7 | 4.6–6.9 | |
| TOTAL e | 0–19 | 37,967 | 88.5 | 88.1–88.8 | 81.3 | 80.9–81.8 | 75.5 | 75.1–76.0 | 72.2 | 71.7–72.7 |
| 20–44 | 52,662 | 87.6 | 87.3–87.9 | 77.8 | 77.4–78.1 | 65.1 | 64.6–65.5 | 54.2 | 53.6–54.7 | |
| 45–54 | 41,351 | 70.1 | 69.7–70.5 | 49.2 | 48.7–49.8 | 34.5 | 34.0–35.0 | 27.9 | 27.4–28.5 | |
| 55–64 | 54,095 | 55.3 | 54.8–55.7 | 33.1 | 32.7–33.5 | 19.8 | 19.4–20.1 | 15.3 | 14.9–15.8 | |
| 65–74 | 48,251 | 38.6 | 38.1–39.0 | 22.1 | 21.7–22.5 | 13.1 | 12.7–13.5 | 10.4 | 9.9–10.8 | |
| 75+ | 42,949 | 19.6 | 19.2–20.0 | 11.8 | 11.5–12.2 | 7.7 | 7.3–8.0 | 6.4 | 6.0–6.9 |
a. The cohort analysis of survival rates was utilized for calculating the survival estimates presented in this table. Long-term cohort-based survival estimates reflect the survival experience of individuals diagnosed over the time period, and they may not necessarily reflect the long-term survival outlook of newly diagnosed cases.
b. Rates are an estimate of the percentage of patients alive at one, two, five, and ten years, respectively.
c. Total number of case that occurred within the NPCR registries between 2001 and 2015.
d. While pilocytic astrocytoma is coded as a tumor of uncertain behavior (/2), the cancer registry community historically codes this histology as a malignant tumor and as a result they are included in this table.
e. Total includes histologies not listed in this table.
- Rates were not presented for categories with 50 or fewer cases and were suppressed for rates where fewer than 16 cases were surviving within a category.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; CI, Confidence Interval; NOS, Not otherwise specified